SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017990
Filing Date
2019-11-19
Accepted
2019-11-19 16:11:19
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 503092
2 ex31-1.htm EX-31.1 18111
3 ex32-1.htm EX-32.1 8242
  Complete submission text file 0001493152-19-017990.txt   3541148

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE endv-20190930.xml EX-101.INS 589458
5 XBRL SCHEMA FILE endv-20190930.xsd EX-101.SCH 58463
6 XBRL CALCULATION FILE endv-20190930_cal.xml EX-101.CAL 53233
7 XBRL DEFINITION FILE endv-20190930_def.xml EX-101.DEF 163687
8 XBRL LABEL FILE endv-20190930_lab.xml EX-101.LAB 385632
9 XBRL PRESENTATION FILE endv-20190930_pre.xml EX-101.PRE 260463
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 191231280
SIC: 2834 Pharmaceutical Preparations